ESG Report 2021

ABOUT THE GROUP The Group is a comprehensive and modernised Laboratories pharmaceutical enterprise involving in the research (“Zhongshan Company”), Guangdong Kaiping and development, production and operation of Kingly Capsule Co., Ltd., (Inner intermediate, bulk medicine and finished products. Mongolia) Co., Ltd. (“Inner Mongolia Company”), The Group currently has six major production sites and The United Animal Healthcare (Inner Mongolia) including The United Laboratories Co., Ltd. ( Hong Co., Ltd. (“The United Animal Healthcare”), with a Kong Company ), Zhuhai United Laboratories Co., total of approximately 13,000 employees. Ltd. (“Zhuhai Company”), Zhuhai United Co., Ltd. Zhongshan Branch United Laboratories “ ” CONCEPT AND VISION INTRODUCTION OF THE GROUP Since its establishment, the Group has been talent training, selection and education mechanism, dedicating to the production of high-quality and has gradually formed a “Friendly, Responsible, pharmaceuticals. All our factories have passed the Hardworking and Efficient” workforce. We always certification of Chinese Good Manufacturing adhere to the vision of “Making Life More Practice (“GMP”), and multiple products have Valuable” to promote the development of obtained official certifications such as the environmental protection and the charity sector with Certification of Suitability to the Monographs of the a high sense of social responsibility. As for European Pharmacopoeia Organisation and the US environmental protection, we have made huge Food and Drug Administration (“FDA”). We adhere investment in creating a green enterprise. We to independent innovations and possess strong actively support charities in multiple fields such as research and development capabilities. Our products education, poverty alleviation and social welfare. Our cover multiple fields including antibiotics, diabetes efforts have been recognised by all walks of society, drugs, nervous system drugs, ophthalmology drugs, which reflected our responsibilities and missions as topical dermatology drugs and others. Many a modern enterprise. scientific and technological achievements of the Group have obtained national patents. In the future, the Group will continue to dedicate its efforts to the creation of an outstanding Chinese Talents are the primary productive force of an pharmaceutical brand, promote the development of enterprise. The Group emphasises high-quality work the national medical and healthcare industry, and force construction, continuously improves human create more high-quality and highly effective resource management, establishes and improves our pharmaceuticals. 4 Love China, For China Corporate Philosophy Making Life More Valuable Corporate Vision Friendly, Responsible, Hardworking and Efficient Business Concept Friendship Equality and Mutual Development , , Business Principle Production of First-class Products, Provision of First-class Service, Training of First-class Talents, and Becoming a Model Pharmaceutical Enterprise Corporate Objective Environmental, Social and Governance Report 2021 The United Laboratories International Holdings Limited